Avanir Pharmaceuticals Sues Actavis and Par Pharmaceutical
- August 12, 2011
Avanir Pharmaceuticals filed two separate suits against Actavis and Par Pharmaceutical over a patent related to compositions of dextromethorphan and quinidine used to treat neurological disorders. 8/10, District of Delaware, 1:2011cv00704; 1:2011cv00705.
Access to the full article is currently available to RPX members only. Please contact us if you need further information.